Voloridge Investment Management, LLC Prometheus Biosciences, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$103.46 - $126.29 $7.03 Million - $8.58 Million	-67,963 Reduced 27.49%	179,285 $19.2 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $1.56 Million - $5.06 Million	43,128 Added 21.13%	247,248 $27.2 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $1.07 Million - $2.23 Million	37,863 Added 22.77%	204,120 $12 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $1.31 Million - $2.28 Million	58,561 Added 54.38%	166,257 $4.69 Million
Q1 2022 May 16, 2022	BUY	$30.13 - $50.0 $3.24 Million - $5.38 Million	107,696 New	107,696 $4.07 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.